Researchers and physicians can now quantify:

  • Capillary density
  • Capillary blood volume
  • Blood flow and red cell velocity
  • Endothelial glycocalyx function

GlycoCheck measures and analyzes microvascular health, and objectively reports a MicroVascular Health Score (MVHS). Lower scores are linked to:

  • Diabetes
  • Hypertension
  • Heart Disease
  • Kidney Disease
  • Stroke
  • Dementia
  • Septic Shock
  • Inflammatory Disorders
  • Compromised Immunity
  • Cancer Metastasis

Endothelial glycocalyx research using GlycoCheck is being conducted in Africa, Asia, Australia, China, Europe, Japan, Russia, South America, and the United States.

GlycoCheck was patented in 2009

Glycocalyx, Endothelium, and Capillary Function Report

GlycoCheck is the only system that allows researchers to unravel the mysteries of microcirculation and how its breakdown contributes to the development of various diseases.


Worldwide Patents Issued:

  • United States
  • Canada
  • Europe (Belgium, Czech Republic, Denmark, France, Germany, Hungary, Ireland, Italy, Norway, Poland, Portugal, Romania, Spain, Sweden, Switzerland, The Netherlands, and United Kingdom)
  • China
  • Japan